CD3-CD16+ (NK) cells are rapidly and markedly affected by interferon β 1b (INFβ1b) therapy in relapsing-remitting MS patients
A.M. Ferrarini, P. Perini, S. Sivieri, P. Bulian, G. Biasi, P. GalloVolume:
90
Year:
1998
Language:
english
DOI:
10.1016/s0165-5728(98)91757-x
File:
PDF, 130 KB
english, 1998